Testing effectiveness (Phase 2)UnknownNCT01795768
What this trial is testing
Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
Who this might be right for
Gastric CancerOesophageal CancerBreast Cancer+1 more
Royal Marsden NHS Foundation Trust 48